Oncology Nurse Helps Patients Be Brave

Article

An oncology nurse started a grassroots campaign that brought together community members and patients on the oncology unit.

After being inspired by one of her patients, Harding Cranford, RN, OCN, an oncology nurse at the Levine Cancer Institute, wanted a way to connect the community with the patients she treated on the oncology unit.

So, the nurse started "Bravery Bags," a program where people can donate items to those going through cancer that can act as a pick-me-up during treatment. What started as a small grassroots campaign spanned into donations coming from across the nation, brightening the days of hundreds of patients.

Read more: Educating the Community While Helping Patients With Cancer

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
Related Content
Image of bone marrow cells

As-Expected Ruxolitinib Starting Dose Outperforms Lower Dosage in Myelofibrosis

Bridget Hoyt
April 25th 2025
Article

Both those receiving either expected or less-than-expected starting dosages of ruxolitinib for myelofibrosis treatment reduced daily dosages over 12 months.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

Graphic reading "FDA Approved" resembling a stamp of approval

FDA Approves 2 Indications for Penpulimab-kcqx in Non-Keratinizing NPC

Bridget Hoyt
April 24th 2025
Article

The FDA approved penpulimab-kcqx combination and monotherapy for non-keratinizing nasopharyngeal carcinoma.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

Anatomic image of a breast

T-DXd Plus Pertuzumab Improves PFS Over THP in HER2+ Metastatic Breast Cancer

Ashling Wahner
April 23rd 2025
Article
Image of red blood cells

Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

Ashling Wahner
April 22nd 2025
Article